A Study of RO7198457 (Personalized Cancer Vaccine [PCV]) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors

Condition:   Tumors Interventions:   Drug: RO7198457;   Drug: Atezolizumab Sponsors:   Genentech, Inc.;   Biontech RNA Pharmaceuticals GmbH Not yet recruiting - verified September 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials